BioWorld MedTech

Nov. 9, 2016

In Asia, regulatory harmonization in med tech clashes with the reality on the ground level

SINGAPORE – Harmonization of regulations throughout the Asia Pacific region has been an ongoing goal in the past 20 years, but regulators across the region are now coming to accept that this particular goal may never be achieved. Read More

More bad news for Valeantin form of warning letter

FDA gives green light to Seaspine's Mariner fixation system ahead of its earnings report

Ng Biotech and Atomo Diagnostics unveil rapid next-gen blood-based hCG diagnostic

Product briefs

Daily M&A

Other news to note

Appointments & advancements

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...